Eisai Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$2 |
Market Cap |
$24.21 B |
Shares Outstanding |
296.57 M |
Public Float |
- |
Eisai Co. Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$2 |
Market Cap |
$16.36 B |
Shares Outstanding |
296.57 M |
Public Float |
- |
Eisai Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY221.12 |
Market Cap |
JPY1.78 T |
Shares Outstanding |
296.57 M |
Public Float |
237.92 M |
Address |
4-6-10 Koishikawa Tokyo Tokyo 112 Japan |
Employees | - |
Website | http://www.eisai.co.jp |
Updated | 07/08/2019 |
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. |